Drug designations, product launches & more — 4 GI company key notes

Here are four updates on GI companies from the past week:

IntegraGen's miRpredX 31-3p test was awarded a CE mark for use in the European Union.

The FDA awarded Innovate Biopharmaceuticals' INN-108 orphan drug designation.

CapsoVision launched its CapsoCloud, an exam management system.

Chemistry World reported on Takeda's vision for the future; it involves a move away from generics and over-the-counter businesses into pharmaceutical research and development.

More articles on gastroenterology: 
GI center to know: Lakeside Endoscopy Center
PPIs included on list of drugs to 'seriously consider deprescribing'
GI leader to know: Dr. Douglas Brouillette of Midwest Gastrointestinal Associates

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months